Research Alliance Corp III 8-K

What Happened

• Research Alliance Corp III announced that its Registration Statement was declared effective on May 19, 2026 and that it consummated its initial public offering on May 21, 2026. The company sold 7,500,000 Class A ordinary shares at $10.00 per share, generating $75,000,000 (gross) from the public offering.
• In connection with the IPO, the company entered into several material agreements (underwriting agreement with Leerink Partners LLC; an Investment Management Trust Agreement with Continental Stock Transfer & Trust Company; a Registration and Shareholder Rights Agreement; indemnity and letter agreements with officers, directors and the Sponsor), and established a trust account to hold the offering proceeds for the benefit of public shareholders.

Key Details

• IPO: 7,500,000 Class A shares at $10.00 each; gross proceeds $75,000,000 (offering closed May 21, 2026).
• Private placement: Sponsor purchased 275,000 Class A shares at $10.00 each for $2,750,000 (closed simultaneously).
• Trust deposit: $75,000,000 of the net proceeds from the IPO and the Private Placement (including the underwriter’s deferred commission of $2,250,000) was deposited in the trustee-held trust account.
• Board changes: Michael F. MacLean and Timothy J. Miller were appointed to the board (effective May 19, 2026) and to key committees; each holds 39,130 Class B ordinary shares following a share capitalization.
• Other agreements: Letter Agreement includes voting commitments for the initial business combination, transfer restrictions, and a 24‑month liquidation provision if an initial business combination is not completed within that period.

Why It Matters

• The filing confirms the company is now publicly funded: proceeds are held in a trustee account for the benefit of public shareholders while the company pursues an initial business combination. That trust structure and the deposit amount are central to shareholder protections and the timing of future deal activity.
• Sponsor and management have equity and contractual rights (private placement shares, Class B shares, registration rights, voting commitments, and indemnities) that affect governance and potential future liquidity events for insiders.
• Investors should note the timeline elements (registration effective May 19, IPO closed May 21, and the 24‑month timeframe referenced in the Letter Agreement) and the transfer restrictions on Private Placement shares, which limit those shares’ resale until after the initial business combination.